YouTube - Long COVID Service Evaluation and Forward Planning: 28th September, 2023
I attended this webinar last night my time. It's posted already on YouTube. 70 minutes in three main sections. This was hosted by a company providing a digital patient reported outcomes measures platform (DPROM).
The first was a good presentation on the statistics from a statistician/epidemiologist at the University of Leeds. The main message is that there is a high symptom and disability burden and that this is lasting.
Generally patients had been completely healthy prior to Covid. Fatigue was the main symptom, followed by cognitive, pain, sleep disturbance, PEM, anxiety/depression and palpitations. Cough and loss of smell and taste were the least reported ongoing symptoms.
There was an associated major reduction in quality of life, employment and financial status. This presentation's data will be formally reported in the next couple of months.
The second presentation was from two physiotherapists co-ordinating the LC service in Bath, Swindon and Wiltshire. There was a recognition that they are learning as they go with this "entirely new disease".
There were some major problems demonstrated, which probably relate to the aforementioned lasting disability statistics. Ie the disease and management model is poorly founded and the service is not helping, merely observing the natural recovery in some. There are unquestionable red flags. I don't know whether @PhysiosforME can help.
They have a virtual multi-disciplinary team with input from doctors: respiratory and cardiology consultants. They have also drafted in neurologists and FND specialists to "enhance their service offer".
They offer a personalised plan to "recover well" and "live well", focusing on "breathing well", "reconditioning", "living well with fatigue".
They have structured a 4-tiered rehab pathway. It is emphasised that this is predicated on the patient's "strong sense of self-efficacy" and "a willingness to change".
Tier 1 offers simple reassurance that "the symptoms are real" and "we believe them". The offer includes "talking therapies" and "singing and breathing".
Tier 4 is for the people with "multiple bio-psycho-social factors impacting engagement/outcome".
The third presentation was about plans for the app, with home use directly by patients.
---
There were over 320 in the audience and throughout presentation 2 I observed multiple comments pushing back on the framing, eg referencing this week's Iwasaki Nature paper.
I attended this webinar last night my time. It's posted already on YouTube. 70 minutes in three main sections. This was hosted by a company providing a digital patient reported outcomes measures platform (DPROM).
The first was a good presentation on the statistics from a statistician/epidemiologist at the University of Leeds. The main message is that there is a high symptom and disability burden and that this is lasting.
Generally patients had been completely healthy prior to Covid. Fatigue was the main symptom, followed by cognitive, pain, sleep disturbance, PEM, anxiety/depression and palpitations. Cough and loss of smell and taste were the least reported ongoing symptoms.
There was an associated major reduction in quality of life, employment and financial status. This presentation's data will be formally reported in the next couple of months.
The second presentation was from two physiotherapists co-ordinating the LC service in Bath, Swindon and Wiltshire. There was a recognition that they are learning as they go with this "entirely new disease".
There were some major problems demonstrated, which probably relate to the aforementioned lasting disability statistics. Ie the disease and management model is poorly founded and the service is not helping, merely observing the natural recovery in some. There are unquestionable red flags. I don't know whether @PhysiosforME can help.
They have a virtual multi-disciplinary team with input from doctors: respiratory and cardiology consultants. They have also drafted in neurologists and FND specialists to "enhance their service offer".
They offer a personalised plan to "recover well" and "live well", focusing on "breathing well", "reconditioning", "living well with fatigue".
They have structured a 4-tiered rehab pathway. It is emphasised that this is predicated on the patient's "strong sense of self-efficacy" and "a willingness to change".
Tier 1 offers simple reassurance that "the symptoms are real" and "we believe them". The offer includes "talking therapies" and "singing and breathing".
Tier 4 is for the people with "multiple bio-psycho-social factors impacting engagement/outcome".
The third presentation was about plans for the app, with home use directly by patients.
---
There were over 320 in the audience and throughout presentation 2 I observed multiple comments pushing back on the framing, eg referencing this week's Iwasaki Nature paper.
Last edited by a moderator: